Taro Pharmaceutical Industries Ltd. has received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for imiquimod cream, 5%.

Taro's imiquimod cream is a prescription pharmaceutical product used for topical treatment of actinic keratosis and external genital warts and is bioequivalent to Aldara cream, 5% of Graceway Pharmaceuticals, LLC.

According to industry sources, imiquimod cream had annual sales of approximately $340 million in the US.

Aldara is a registered trademark of Graceway Pharmaceuticals, LLC.

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products.